Literature DB >> 17029869

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.

H Kreis1, C R Loehberg, M P Lux, S Ackermann, W Lang, M W Beckmann, P A Fasching.   

Abstract

AIMS: The aim of this study was to analyze patients' port-related quality of life. PATIENTS AND METHODS: 260 consecutive patients with gynecological or breast malignancies were asked to take part in a questionnaire-based survey including 26 questions, and 232 women agreed to participate in the study. The questionnaire inquired about port-related aspects of everyday life and the use of a central venous access port device for chemotherapy and supportive cancer care. Multivariate analysis was used to identify parameters associated with satisfaction and dissatisfaction in relation to the port.
RESULTS: Most of the women were very satisfied with the use of a port to provide venous access for chemotherapy and supportive cancer care. Faster hospital procedures, good cosmetic results, and the ability to cope with the social environment had a significant influence on the degree of satisfaction. Fear of port punctures, inconvenient heparinization of the port, and fear of complications were found to be negative variables associated with the method.
CONCLUSIONS: Port catheters are well accepted by patients for chemotherapy and supportive cancer care. Generally ports should be rapidly removed after the end of antineoplastic treatment in order to improve patients' satisfaction with the procedure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029869     DOI: 10.1016/j.ejso.2006.08.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  16 in total

1.  Provider Differences in Use of Implanted Ports in Older Adults With Cancer.

Authors:  Allison Lipitz-Snyderman; Elena B Elkin; Coral L Atoria; Camelia S Sima; Andrew S Epstein; Victoria Blinder; Kent A Sepkowitz; Peter B Bach
Journal:  Med Care       Date:  2015-07       Impact factor: 2.983

2.  Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.

Authors:  Gabriel Liberale; Michel El Houkayem; Claire Viste; Fikri Bouazza; Michel Moreau; Issam El Nakadi; Isabelle Veys
Journal:  Support Care Cancer       Date:  2016-08-05       Impact factor: 3.603

3.  Prioritizing the expenses of breast cancer treatment makes sense- not just in developing countries, but across the globe.

Authors:  Kul Ranjan Singh; Gaurav Agarwal
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

4.  Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients.

Authors:  Moritz Wildgruber; Sebastian Borgmeyer; Bernhard Haller; Heike Jansen; Jochen Gaa; Marion Kiechle; Reinhard Meier; Johannes Ettl; Hermann Berger
Journal:  Eur Radiol       Date:  2014-09-20       Impact factor: 5.315

5.  No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial.

Authors:  Roberto Biffi; Franco Orsi; Simonetta Pozzi; Andrea Maldifassi; Davide Radice; Nicole Rotmensz; Maria Giulia Zampino; Nicola Fazio; Giulia Peruzzotti; Florence Didier
Journal:  Support Care Cancer       Date:  2010-08-28       Impact factor: 3.603

6.  Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer.

Authors:  Allison Lipitz-Snyderman; Qinli Ma; Michael F Pollack; John Barron; Elena B Elkin; Peter B Bach; Jennifer L Malin
Journal:  J Oncol Pract       Date:  2015-08-11       Impact factor: 3.840

7.  Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.

Authors:  Véronique Merle; Hélène Marini; Frédéric Di Fiore; Marion Lottin; Christian Gray; Agnès Loeb; Akpéné Fred; Nathalie Contentin; Jean-François Muir; Luc Thiberville; Christian Pfister; Emmanuel Huet; Christophe Peillon; Pierre Michel; Pierre Czernichow
Journal:  Support Care Cancer       Date:  2015-10-10       Impact factor: 3.603

8.  Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.

Authors:  Kul Ranjan Singh; Gaurav Agarwal; Gitika Nanda; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra; Puneet Goyal
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

9.  Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.

Authors:  Caoimhe Ryan; Hannah Hesselgreaves; Olivia Wu; Jonathan Moss; James Paul; Judith Dixon-Hughes; Evi Germeni
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

10.  Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer.

Authors:  Jie Zhou; Shikun Qian; Weixing He; Guodong Han; Hongsheng Li; Rongcheng Luo
Journal:  World J Surg Oncol       Date:  2014-12-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.